Innovative Medicine
At Johnson & Johnson Innovative Medicine, we’re creating a future where disease is a thing of the past. We’re working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.
We focus on areas of medicine where we can make the biggest difference: Infectious Diseases and Vaccines, Oncology, Immunology, Neuroscience, Pulmonary Hypertension, and Cardiovascular and Metabolism.
We focus on areas of medicine where we can make the biggest difference: Infectious Diseases and Vaccines, Oncology, Immunology, Neuroscience, Pulmonary Hypertension, and Cardiovascular and Metabolism.
Our focus
Infectious diseases and vaccines
At Johnson & Johnson Innovative Medicine, our fight against infectious diseases is a global effort. From viral hepatitis and human immunodeficiency virus (HIV) to pathogens of global concern. We strive to discover and develop novel therapeutics and vaccines to help prevent, treat and utlimately cure infectious diseases worldwide, improving treatment outcomes and patients’ lives.
With goals like these, there’s no time to waste. That’s why the team focuses on internal discovery and world-class development of therapeutics and vaccines whilst seeking out partnerships across the world to connect our expertise with others. We believe these problems can be conquered the same way all of humanity’s greatest problems have been solved: persistent effort and game-changing innovation.
With goals like these, there’s no time to waste. That’s why the team focuses on internal discovery and world-class development of therapeutics and vaccines whilst seeking out partnerships across the world to connect our expertise with others. We believe these problems can be conquered the same way all of humanity’s greatest problems have been solved: persistent effort and game-changing innovation.
Oncology
We envision a world where cancer is a preventable, chronic or curable disease. To get there, we’re focused on pursuing new pathways that can help to prolong and improve patient lives.
In Oncology, our goal is to fundamentally alter the way cancer is understood, diagnosed, and managed. One of the innovative ways that we approach this challenge is via cancer interception. We are striving to achieve a more robust understanding of the mechanisms underlying the transition of normal cells to a pre-malignant state, with the goal of developing products capable of intercepting cancer at its earliest stages, when patients are healthier and more likely to benefit.
In Oncology, our goal is to fundamentally alter the way cancer is understood, diagnosed, and managed. One of the innovative ways that we approach this challenge is via cancer interception. We are striving to achieve a more robust understanding of the mechanisms underlying the transition of normal cells to a pre-malignant state, with the goal of developing products capable of intercepting cancer at its earliest stages, when patients are healthier and more likely to benefit.
Immunology
Over the past decade, Johnson & Johnson Innovative Medicine has redefined the standard of care in immunology. With a rich heritage in developing cutting-edge treatments that can help to address the needs of millions of patients living with autoimmune and inflammatory diseases. Johnson & Johnson Innovative Medicine strives to change the way diseases are treated; pursuing new pathways that could prevent, intercept and ultimately cure, and expanding our portfolio beyond monoclonal antibodies to include novel, oral small molecules and new biologic platforms. Through our ongoing efforts in discovery, biomarkers, clinical research and external innovation, we are poised for continued leadership, bringing transformational medicines to patients and healthcare providers to achieve our vision: a world free from immune diseases.
Neuroscience
At Johnson & Johnson Innovative Medicine, we are focused on pushing the boundaries of medicine- to help resolve some of the most challenging medical conditions of our time. Mental health has been an important part of our heritage since our company was founded and we remain committed to reducing the burden, disability and devastation caused by mental health disorders.
We continue to invest in expanding treatment options, even as many companies have moved away from neuroscience because of its complexity and risk. We are immensely proud of the many ground-breaking mental health products Johnson & Johnson Innovative Medicine has pioneered over the course of our 60+ year legacy in field.
We continue to invest in expanding treatment options, even as many companies have moved away from neuroscience because of its complexity and risk. We are immensely proud of the many ground-breaking mental health products Johnson & Johnson Innovative Medicine has pioneered over the course of our 60+ year legacy in field.
Pulmonary Hypertension
The integration of Actelion into Johnson & Johnson Innovative Medicine in 2017, saw PH established as our sixth disease area strong hold. We aim to build upon the strong heritage of Actelion, where in the past two decades, the prognosis and quality of life for people with PH has significantly improved.
Together, we have a clear strategy to transform lives through closing the diagnosis gap and building an innovative pipeline. Johnson & Johnson Innovative Medicine is committed to improving PH patient outcomes for the long haul. This means holistically addressing unmet needs across the patient journey, including faster diagnosis, better monitoring and new treatment approaches, including novel therapeutic devices, digital health solutions and non-invasive diagnostics to aid faster referral to specialist care.
Together, we have a clear strategy to transform lives through closing the diagnosis gap and building an innovative pipeline. Johnson & Johnson Innovative Medicine is committed to improving PH patient outcomes for the long haul. This means holistically addressing unmet needs across the patient journey, including faster diagnosis, better monitoring and new treatment approaches, including novel therapeutic devices, digital health solutions and non-invasive diagnostics to aid faster referral to specialist care.
Cardiovascular and Metabolism
Johnson & Johnson Innovative Medicine has an enduring commitment to researching the prevention and treatment of cardiovascular and metabolic diseases. Our aim is to develop innovative healthcare solutions that will significantly improve outcome for patients. As such, we are building a comprehensive approach to diabetes care as well as cardiovascular disease, uncovering new therapies we hope will improve the quality of life for patients.
Our mission is global, local and personal. Together, we can reshape the future of cardiovascular and metabolic disease prevention and treatment.
Our mission is global, local and personal. Together, we can reshape the future of cardiovascular and metabolic disease prevention and treatment.